Rita Moos

1.1k total citations
22 papers, 830 citations indexed

About

Rita Moos is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Rita Moos has authored 22 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Neurology and 4 papers in Oncology. Recurrent topics in Rita Moos's work include Prion Diseases and Protein Misfolding (15 papers), Neurological diseases and metabolism (5 papers) and Viral-associated cancers and disorders (4 papers). Rita Moos is often cited by papers focused on Prion Diseases and Protein Misfolding (15 papers), Neurological diseases and metabolism (5 papers) and Viral-associated cancers and disorders (4 papers). Rita Moos collaborates with scholars based in Switzerland, United States and Italy. Rita Moos's co-authors include Adriano Aguzzi, Jeppe Falsig, Anna Maria Calella, Mario Nuvolone, Mélissa Farinelli, Isabelle M. Mansuy, Magdalini Polymenidou, Petra Schwarz, Werner Kempf and Gino Miele and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Rita Moos

22 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita Moos Switzerland 14 614 338 261 192 109 22 830
Stine Rasmussen Denmark 10 147 0.2× 259 0.8× 34 0.1× 152 0.8× 66 0.6× 10 729
Rico Frigg Switzerland 13 1.3k 2.1× 544 1.6× 87 0.3× 435 2.3× 24 0.2× 19 1.4k
Minghai Zhou China 8 322 0.5× 85 0.3× 118 0.5× 37 0.2× 137 1.3× 12 617
Alexa Ertmer Germany 7 371 0.6× 118 0.3× 114 0.4× 67 0.3× 215 2.0× 7 565
Ian Sylvester United Kingdom 8 642 1.0× 67 0.2× 88 0.3× 108 0.6× 21 0.2× 10 796
Vincenza Campana France 12 685 1.1× 274 0.8× 169 0.6× 245 1.3× 26 0.2× 13 756
Doron Shmerling Switzerland 9 817 1.3× 420 1.2× 69 0.3× 311 1.6× 15 0.1× 14 900
Regina Reimann Switzerland 9 324 0.5× 209 0.6× 92 0.4× 107 0.6× 14 0.1× 27 484
Ferenc Garzuly Hungary 13 393 0.6× 90 0.3× 204 0.8× 19 0.1× 63 0.6× 37 918
Eleonora Piras Italy 10 277 0.5× 104 0.3× 42 0.2× 17 0.1× 66 0.6× 13 597

Countries citing papers authored by Rita Moos

Since Specialization
Citations

This map shows the geographic impact of Rita Moos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Moos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Moos more than expected).

Fields of papers citing papers by Rita Moos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Moos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Moos. The network helps show where Rita Moos may publish in the future.

Co-authorship network of co-authors of Rita Moos

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Moos. A scholar is included among the top collaborators of Rita Moos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Moos. Rita Moos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lakkaraju, Asvin KK, Silvia Sorce, Assunta Senatore, et al.. (2022). Glial activation in prion diseases is selectively triggered by neuronal PrPSc. Brain Pathology. 32(5). e13056–e13056. 20 indexed citations
3.
Moos, Rita, et al.. (2020). Prion infection, transmission, and cytopathology modeled in a low-biohazard human cell line. Life Science Alliance. 3(8). e202000814–e202000814. 8 indexed citations
4.
Ballmer, Boris, Rita Moos, Prisca Liberali, et al.. (2017). Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay. Journal of Biological Chemistry. 292(20). 8356–8368. 12 indexed citations
5.
Nuvolone, Mario, Marta Paolucci, Silvia Sorce, et al.. (2017). Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling. PLoS ONE. 12(5). e0177876–e0177876. 6 indexed citations
6.
Nuvolone, Mario, Gino Miele, Silvia Sorce, et al.. (2017). Cystatin F is a biomarker of prion pathogenesis in mice. PLoS ONE. 12(2). e0171923–e0171923. 18 indexed citations
7.
Frontzek, Karl, Silvia Sorce, Assunta Senatore, et al.. (2016). Neurotoxic Antibodies against the Prion Protein Do Not Trigger Prion Replication. PLoS ONE. 11(9). e0163601–e0163601. 16 indexed citations
8.
Zhu, Caihong, U. Herrmann, Bei Li, et al.. (2015). Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains. Neurobiology of Aging. 36(5). 1994–2003. 30 indexed citations
9.
Frontzek, Karl, et al.. (2015). Iatrogenic and sporadic Creutzfeldt-Jakob disease in 2 sisters without mutation in the prion protein gene. Prion. 9(6). 444–448. 5 indexed citations
10.
Polymenidou, Magdalini, Stefan Prokop, Hans H. Jung, et al.. (2010). Atypical Prion Protein Conformation in Familial Prion Disease with PRNP P105T Mutation. Brain Pathology. 21(2). 209–214. 18 indexed citations
11.
Calella, Anna Maria, Mélissa Farinelli, Mario Nuvolone, et al.. (2010). Prion protein and Aβ‐related synaptic toxicity impairment. EMBO Molecular Medicine. 2(8). 306–314. 209 indexed citations
12.
Kranich, Jan, Nike Julia Kräutler, Jeppe Falsig, et al.. (2010). Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain–dependent manner. The Journal of Experimental Medicine. 207(10). 2271–2281. 91 indexed citations
13.
Rutishauser, Dorothea, Kirsten D. Mertz, Rita Moos, et al.. (2009). The Comprehensive Native Interactome of a Fully Functional Tagged Prion Protein. PLoS ONE. 4(2). e4446–e4446. 65 indexed citations
14.
Polymenidou, Magdalini, Rita Moos, Mike Scott, et al.. (2008). The POM Monoclonals: A Comprehensive Set of Antibodies to Non-Overlapping Prion Protein Epitopes. PLoS ONE. 3(12). e3872–e3872. 146 indexed citations
15.
Polymenidou, Magdalini, Heidi Trusheim, Rita Moos, et al.. (2008). Canine MDCK cell lines are refractory to infection with human and mouse prions. Vaccine. 26(21). 2601–2614. 41 indexed citations
17.
Kempf, Werner, et al.. (1995). Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma: No evidence for an etiological association. Human Pathology. 26(8). 914–919. 27 indexed citations
18.
Kempf, Werner, et al.. (1995). Detection of several types of human papilloma viruses in AIDS‐associated Kaposi's sarcoma. Journal of Medical Virology. 46(3). 189–193. 18 indexed citations
19.
Adams, Volker, et al.. (1995). MUTATIONAL ANALYSIS OF THE TUMOR-SUPPRESSOR GENE WT1 - DETECTION OF A NOVEL HOMOZYGOUS POINT MUTATION IN SPORADIC UNILATERAL WILMS-TUMOR. International Journal of Oncology. 7(5). 1103–7. 9 indexed citations
20.
Kempf, Werner, et al.. (1994). [Detection of human herpesvirus type 6, human herpesvirus type 7, cytomegalovirus and human papillomavirus in cutaneous AIDS-associated Kaposi's sarcoma].. PubMed. 78. 260–4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026